WORLD ISSUE

Title: Is Clorox Still a Safe Choice? What Dividend Investors Should Know Right Now

When it comes to investing in consumer staples, The Clorox Company (NYSE: CLX) has long been considered a safe shelter in volatile markets. With its strong dividend history and familiar household brands, Clorox seemed like the kind of stock you could buy and forget. But recent updates from JPMorgan suggest it might be time to rethink your assumptions. Let’s dive into what’s happening with Clorox—and what it means for long-term, income-seeking investors.

What’s Going On With Clorox?

On October 10, JPMorgan analyst Andrea Teixeira revised Clorox’s price target from $135 to $127 while maintaining a 'Neutral' rating. That may not sound dramatic at first glance, but the reasons behind that change are worth examining carefully.

JPMorgan cited slowing demand in both the U.S. and Western European markets, along with aggressive inventory reductions by retailers. This combination doesn't bode well for short-term revenue or earnings. And Clorox isn't alone—many companies in the household and personal care sectors are facing similar headwinds.

📉 For investors who have relied on Clorox as a stable performer, these signs may be a reason for caution.

Silver Lining: Dividend Strength Still Shines

Despite the drop in demand, there’s one area where Clorox continues to impress: its dividend.

🔥 Clorox has increased its dividend for 22 consecutive years.
💸 Its current quarterly dividend is $1.24 per share.
📈 That translates to a dividend yield of 4.16% as of October 14.

Even better, the company reported strong cash flow performance in 2024, with net cash from operations jumping 41% year-over-year ($981 million in 2024 vs $695 million in 2023).

💬 “Cash is king,” especially in uncertain times. And for dividend investors, Clorox’s cash flow metrics suggest the company can continue rewarding shareholders—even amid sluggish demand.

Should You Buy, Hold, or Sell?

Let’s be real: Clorox might not be the growth story it once was.

If your strategy is focused on income through dividends and you’re willing to accept lower short-term returns, Clorox still deserves a spot on your watchlist. Its reliable payouts make it a great choice for retirees or risk-averse investors.

However, if you're looking for total return potential, there may be better opportunities elsewhere. JPMorgan's revised guidance reflects a broader trend that you shouldn't ignore—consumer behavior is shifting, and Clorox may need time to adjust.

Better Alternatives? AI Stocks Take the Spotlight

Interestingly, sources suggest that AI-related stocks may offer better upside with less downside risk compared to consumer staples like Clorox right now.

🚀 One particularly overlooked AI stock (highlighted in Insider Monkey’s free report) is expected to majorly benefit from Trump-era tariffs and onshoring trends. If you’re willing to take on more risk for bigger gains, now might be a smart time to diversify your portfolio.

👉 Tip: Look for companies innovating in automation, semiconductors, and data management—sectors poised to grow long-term, regardless of short-term volatility.

Final Thoughts

Clorox remains a classic example of a steady, reliable dividend stock—but it’s not immune to global economic shifts. While its dividend record remains spotless, its growth story is clearly facing serious challenges.

📌 Bottom Line:
Hold Clorox if you’re income-focused.
Seek dynamic sectors like AI if you're chasing growth.

Whether you stay with Clorox or pivot, the most important step is staying informed—and keeping your investment strategy aligned with your personal financial goals.

✅ Want more reliable dividend stocks?
Check out "12 Best Dividend Stocks With Yields Above 4%" for ideas you can trust through any market cycle.

📊 Prefer growth?
Don’t miss our exclusive guide: "3 AI Megatrends & The One Stock to Watch Right Now".

Stay smart. Stay diversified.

#InvestingTips #DividendStocks #AIStocks #Clorox #StockMarket2025 #JPMorgan #FinanceBlog